Takeda CEO Julie Kim Sees Return to Growth Within Three Years
2026-06-25 09:49:10
Takeda Pharmaceutical Co.’s newly appointed Chief Executive Officer Julie Kim said the company expects to return to growth in two to three years as it prepares for a wave of product launches, according to Bloomberg.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
